A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2007
12/25/2007	US7312360 Substituted hydroxyethylamines
12/25/2007	US7312358 Dysmenorrhea; congestive heart failure; liver disorders; vision defects
12/25/2007	US7312344 Dimeric isoflavones
12/25/2007	US7312342 Process for the preparation of (3-cyano-1h-indol-7-yl) (4-(4-fluorophenethyl) piperazin-1-yl)-methanone and salts thereof
12/25/2007	US7312328 Antiinflammatory agents; autoimmune disease; rheumatic diseases; multiple sclerosis; respiratory system disorders
12/25/2007	US7312321 Antibody to human enzymes of the metalloprotease family
12/25/2007	US7312304 Somatostatin agonists
12/25/2007	US7312238 Nonsedating α-2 agonists
12/25/2007	US7312234 Chemokine receptor binding heterocyclic compounds
12/25/2007	US7312231 Quaternization of compound for treatment of urogenital disorders, respiratory system disorders or gastrointestinal disorders
12/25/2007	US7312230 Carboxylic acid derivatives as IP antagonists
12/25/2007	US7312224 Pyrimidine derivatives
12/25/2007	US7312223 8-Amino-7-phenylmethyl-1-ethyl-3,7-dihydro-3-(2-hydroxyethyl)-purine-2,6-dione derivatives; urogenital, respiratory system, kidney, cardiovascular, autoimmune or brain disorders; angina pectoris, hypertension, restenosis; anticarcinogenic, hypoglycemic, antiischemic, and hypotensive agents; diabetes
12/25/2007	US7312219 Antidiabetic agents
12/25/2007	US7312211 Cathepsin S, K, F, L and B reversible inhibitory amidino and guanidino peptidyl compounds useful for treating autoimmune diseases, rheumatoid arthritis, multiple sclerosis, asthma and osteoporosis
12/25/2007	US7312209 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives
12/25/2007	US7312208 Quaternary ammonium compounds
12/25/2007	US7312190 Pharmaceutical compositions of apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
12/25/2007	US7311913 humanized monoclonal antibodies against human antihemophilic factor, used as antithrombotic agents, for treatment of strokes, ischemia, angina, necrosis, thrombosis, anemia, urogental disorders, thrombocytopenia or restenosis; cardiovascular disorders
12/25/2007	US7311905 Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
12/21/2007	WO2007146981A2 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase c-alpha
12/21/2007	WO2007146900A2 Antihypertensive therapy method
12/21/2007	WO2007145909A2 Methods and compositions for treating post-myocardial infarction damage
12/21/2007	WO2007145563A1 Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor
12/21/2007	WO2007145306A1 Element having long blood-circulating time which is degradable selectively in tumor tissue
12/21/2007	WO2007145191A1 Coated tablet
12/21/2007	WO2007144669A1 Pyrazolo[1,5-a]quinazolin-5(4h)-ones as inhibitors of poly(adp-ribose)polymerase (parp)
12/21/2007	WO2007144501A2 Use of a vasopeptidase inhibitor for the treatment of pulmonary arterial hypertension
12/21/2007	WO2007144204A1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
12/21/2007	WO2007144202A1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
12/21/2007	WO2007144128A1 Pyrrolidine compounds as renin inhibitors
12/21/2007	WO2007144082A2 Combination antihypertensive wafer
12/21/2007	WO2007143951A1 COMPOUNDS WITH THE ACTIVITY OF PPARγ AGONIST AND APPLICATION THEREOF
12/21/2007	WO2007143897A1 A compound with special property, compositon comprising the compound and its preparation and uses
12/21/2007	WO2007126771A3 Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonists
12/21/2007	WO2007120523A3 6-(aminoalkyl)indazoles
12/21/2007	WO2007118963A3 Substituted n-(phenethyl)benzamide derivatives, preparation and uses thereof
12/21/2007	WO2007106236A3 Pyrrolo-pyridine kinase modulators
12/21/2007	WO2007106063A3 Methods for increasing blood flow and/or promoting tissue regeneration
12/21/2007	WO2007099509A3 Primary amines as renin inhibitors
12/21/2007	WO2007089787A3 Compositions and methods for treating cardiovascular, cerebrovascular and other vascular disease patients
12/21/2007	WO2007050783A3 Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
12/21/2007	WO2007016338A3 Use of chk2 kinase inhibitors for cancer treatment
12/21/2007	WO2006116949A8 A new bacillus subtilis strain and its use in preparing medicine for treating thrombosis
12/21/2007	CA2655144A1 Antihypertensive therapy method
12/21/2007	CA2655019A1 Use of a vasopeptidase inhibitor for the treatment of pulmonary arterial hypertension
12/21/2007	CA2654987A1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
12/21/2007	CA2654979A1 Pyrrolidine compounds as renin inhibitors
12/21/2007	CA2654789A1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them
12/21/2007	CA2654250A1 Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor
12/21/2007	CA2654211A1 Combination antihypertensive wafer
12/21/2007	CA2653777A1 2-anilino-4-(heterocyclic)amino-pyrimidines
12/20/2007	US20070294107 Uses Of Endopeptidases In Treatment Of Disease
12/20/2007	US20070293937 Endoluminal medical device for local delivery of cathepsin inhibitors, method of making and treating
12/20/2007	US20070293587 Combating sinus, throat, and blood infections with xylitol delivered in the mouth
12/20/2007	US20070293579 Use of carp inhibitors for the treatment of heart diseases
12/20/2007	US20070293572 Anti-Fatigue Composition
12/20/2007	US20070293570 Pharmaceutical uses for alpha2delta ligands
12/20/2007	US20070293555 4-methoxy-benzoic acid 1-imidazol-1-yl methyl-2-(4-fluorophenoxy)-ethyl ester; N-[(1-imidazol-1-yl methyl)-2-phenoxy-ethyl]-4-iodo-benzamide; cancer, inflammation, septic shock, infertility, preterm labor, pain, or an ischemia
12/20/2007	US20070293544 Novel 4-Arylamino Pyridone Derivatives as Mek Inhibitors for the Treatment of Hyper-Proliferative Disorders
12/20/2007	US20070293535 Nuclear Transfer Promoter for Ddc42 Protein and Method of Screening the Dame
12/20/2007	US20070293529 Tetrasubstituted ureas as modulators of 11-beta hydroxyl steroid dehydrogenase type 1
12/20/2007	US20070293527 1-Methyl-1,3,4,5,6,11b-hexahydro-2H-11-oxa-4a-aza-benzo[a]fluoren-1-ol; alpha 2C adrergic receptors; adrenergic blocking agents; central nervous system; cognition activators; antidepressants; anxiolytic agents; peripheral nervous syster; antidiabetic agents; hypertensive agents; Raynaud's disease
12/20/2007	US20070293519 Analogs of thalidomide as potential angiogenesis inhibitors
12/20/2007	US20070293513 Cristalline and amorphous form of a triazolo (4,5-d) pyridimine compound
12/20/2007	US20070293511 Crf Receptor Antagonists and Methods
12/20/2007	US20070293496 Nitrogen containing heterocyclic compounds and medicines containing the same
12/20/2007	US20070293489 Substituted Pyrazolopyrimidines
12/20/2007	US20070293484 Thiophene Heteroaryl Amines
12/20/2007	US20070293474 Combination of a DPP IV inhibitor and a cardiovascular compound
12/20/2007	US20070293464 Substituted Pyrimidine Compositions and Methods of Use
12/20/2007	US20070293461 Biphenyl compounds useful as muscarinic receptor antagonists
12/20/2007	US20070293444 Novel Nucleoside Transport Inhibitors
12/20/2007	US20070293442 Antithrombotic compound
12/20/2007	US20070293431 Method for improving neurotransmission failure using a novel agent
12/20/2007	US20070293419 Stable, Aqueous Solution of Human Erythropoietin, Not Containing Serum Albumin
12/20/2007	US20070293418 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive and nervous system disorders
12/20/2007	US20070292513 Pazopanib hydrochloride and synthesis, chemical intermediates, and dosage forms thereof; anticancer; colon cancer, breast cancer
12/20/2007	US20070292471 Nitric Oxide-Releasing Diazeniumdiolated Acrylonitrile-Based Polymers, and Compositions, Medical Devices, and Uses Thereof
12/20/2007	DE10325813B4 Prophylaxe und/oder Therapie bei der portalen Hypertonie Prophylaxis and / or therapy of portal hypertension in
12/20/2007	DE102006027794A1 Antihypertonie-Kombinationswafer Antihypertensive combination wafer
12/19/2007	EP1867648A1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them.
12/19/2007	EP1867647A1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them.
12/19/2007	EP1867343A2 Novel compounds
12/19/2007	EP1867342A1 Agents for ameliorating troubles following cerebrovascular failure and inhibiting progress thereof
12/19/2007	EP1867333A1 Pharmaceutical composition comprising condensed indole compound
12/19/2007	EP1867331A1 Triazole derivative and the use thereof
12/19/2007	EP1866416A2 Delivery systems and methods for diagnosing and treating cardiovascular diseases
12/19/2007	EP1866415A2 A cysteine-containing peptide tag for site-specific conjugation of proteins
12/19/2007	EP1866323A2 Glucuronidated nebivolol
12/19/2007	EP1865976A1 Use of natriuretic peptide for treating heart failure
12/19/2007	EP1865954A2 Methods for avoiding edema in the treatment or prevention of ppar gamma-responsive diseases, including cancer
12/19/2007	EP1865951A1 Method for preventing cardiovascular diseases
12/19/2007	EP1865950A1 Compounds useful as modulators of the proteasome activity
12/19/2007	EP1865949A2 Modulators of atp-binding cassette transporters
12/19/2007	EP1865945A1 Combination therapy for endothelial dysfunction, angina and diabetes
12/19/2007	EP1865928A1 Nanoparticulate biphosphonate compositions
12/19/2007	EP1865779A2 Compositions and methods for ameliorating cachexia
12/19/2007	EP1865778A2 Methods for avoiding edema in the treatment of metabolic, inflammatory, and cardiovascular disorders
12/19/2007	EP1865770A2 The genetic risk assessment in heart failure: impact of the genetic variation of nos3

1 ... 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 ... 1595